Stay updated on UC-961 in Relapsed CLL Clinical Trial

Sign up to get notified when there's something new on the UC-961 in Relapsed CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the UC-961 in Relapsed CLL Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now shows Revision: v3.5.4 instead of Revision: v3.5.3. This is an administrative version update and does not alter the study details or page functionality.
    Difference
    0.1%
    Check dated 2026-05-14T23:07:53.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.3 replacing Revision: v3.5.2, indicating a software update to the platform rather than a change to the study details or content.
    Difference
    0.1%
    Check dated 2026-04-30T17:32:28.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision history updated: v3.5.0 removed and v3.5.2 added.
    Difference
    0.1%
    Check dated 2026-04-16T11:08:28.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Added B-cell chronic lymphocytic leukemia as a condition term and included Genetic and Rare Diseases Information Center as a resources entry.
    Difference
    0.2%
    Check dated 2026-04-02T04:48:46.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Revision history updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T18:04:39.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This update does not modify study data or page content.
    Difference
    0.1%
    Check dated 2026-03-11T14:43:06.000Z thumbnail image

Stay in the know with updates to UC-961 in Relapsed CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the UC-961 in Relapsed CLL Clinical Trial page.